News

Xentria's latest news and updates about the development
of future biologic and biosimilar products.

Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

Published on Jun 22 2021

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

Published on May 20 2021

Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis

Important Regulatory Milestone Provides Runaway to Move XTMAB-16 into the Clinical Phase

Published on Mar 03 2021

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Published on Dec 15 2020

This website uses cookies

We use cookies to improve your experience on our site. You can read more about our Cookie Policy in our Privacy policy.